An organ culture chimera system was used to assess the effect of human immunodeficiency virus type 1 (HIV-1) infection on the T cell -generation capacity of precursors derived from human peripheral blood. Peripheral blood mononuclear cells from HIV-1 -infected patients and uninfected controls were placed on fetal thymus lobes of NOD/LtSz-scid/scid mice. Blood from the HIV-1 -infected patients consistently produced fewer CD4 and CD8 cells compared with blood from controls (P õ .01). Addition of zidovudine to the cultures did not alter this profile. Limit dilution experiments suggested that there were fewer functional precursors in the infected patients. These results were not dependent on the patient's level of peripheral CD4 cells; even samples from patients with normal CD4 cell counts were unable to generate T cells in organ cultures. The results are consistent with a loss in the capacity of HIV-1 -infected patients to produce functional T cell progenitors in their peripheral blood.
Infection with human immunodeficiency virus type 1 (HIV-1)
Model systems have been developed recently to more directly address the mechanisms involved in CD4
/ T cell depleis characterized by progressive depletion in the number of CD4 / T lymphocytes circulating in the peripheral blood. As tion during HIV-1 infection. One of these models is the SCIDhu mouse model, in which human fetal thymus is colonized the primary site for production and selection of T cells, the thymus is the first site at which CD4 / T cells are produced. It with stem cells from human fetal liver under the kidney capsule of an immunoincompetent scid/scid mouse (e.g., C.B-17 scid/ has been previously shown that the thymus of children infected with HIV-1 is atrophied [1] , with severe depletion of lymphoscid). Human T cells developing in these systems can be infected successfully with HIV-1, resulting in a thymic pathology cytes, Hassal's corpuscles, and thymic epithelial cells [2] . In a 3-day-old neonatal subject with HIV-1 infection, levels of that is very similar to that observed in HIV-1 -infected pediatric patients [7] . An in vitro organ culture system for human thymus CD4 /
CD8
/ and CD4 / CD8 0 cells were low, suggesting that HIV-1 infection depletes T cells at a very early stage of their has also been reported that can be infected by HIV-1 with similar results [8] . These observations indicate that T cell dedifferentiation [3] .
In addition, HIV-1 infection diminishes the capacity of adult velopment is abnormal in persons infected with HIV-1.
With the models of T cell development and HIV-1 infection bone marrow to generate new cells of the erythrocyte, granulocyte, and megakaryocyte lineages [4, 5] . Hematopoeitic cells utilizing human thymic tissue to support T cell differentiation, it has been difficult to distinguish the effects of HIV-1 infection in fetal and adult life are derived from CD34 / stem cells in the bone marrow. A small subset of these cells have been on T cell precursors from the effects on thymic stroma. To obviate this problem, we have used a xenogeneic in vitro organ shown to be infected with HIV-1 in some adult patients [6] . These data suggest that bone marrow of HIV-1 -infected paculture system [9] , which can be infected with HIV-1 [10] , to examine the effects of HIV-1 infection on T cell development. tients also would have a diminished capacity to develop T cells.
This system uses murine fetal thymus lobes as recipients for T progenitor cells from the peripheral blood of HIV-1 -infected patients. Since HIV-1 does not infect murine stromal cells, the lobes were removed from 14-to 16-day gestation mouse fetuses Flow cytometry. Cells from collagenase digestion were stained for three-color flow cytometry with monoclonal antibodies to huand placed in organ culture as described previously [10] .
Human subjects. HIV-1-infected male subjects (13) and uninman surface molecules CD3 (fluorescein), CD8 (phycoerythrin), and CD4 (tricolor) as described [9] . All monoclonal antibodies fected controls (3 male; 3 female) were recruited from the Tucson VA Medical Center. As shown in assessed by trypan blue exclusion of cells counted in a hemocytom-(Hyclone, Salt Lake City), 1 mg/mL penicillin, 1 U/mL streptomyeter. These data were entered into a statistical program (Statview; cin, and 3.4 g/L sodium bicarbonate and maintained at 37ЊC with Abacus, Berkeley, CA), which provided the mean { SE for each 5% CO 2 . Then 10 5 total PBMC were placed on each of the lobes, data point. Differences between nonpaired continuous data in 2 unless otherwise noted, as described [9] . In brief, cells were placed groups were analyzed by use of Student's t test. Differences beon each thymus lobe by direct application of broken pellets of tween nonpaired continuous data in ú2 groups or data with recells in 0.2-mL aliquots until the designated total number of donor peated measures were analyzed by analysis of variance (ANOVA). cells per lobe was reached. In some experiments, 1 mg/mL (4 mM)
A P value with 95% confidence was considered statistically sig-3-azido-3-deoxythymidine (zidovudine; Sigma) was added to the nificant. organ culture medium. This amount is 4 times the dose previously
Reverse transcriptase (RT) assay. HIV-1 replication in culture reported to inhibit the effects of HIV-1 in organ culture [8] . After was determined by RT assay, using supernatant from 12-day culthe designated number of days in culture, lobes were enzymatically tures as described [12, 13] . The amount of RT activity was exdigested in collagenase [11] and stained for three-color flow cypressed as counts per minute (cpm) per milliliter. HIV-1 NL4-3 (from tometry. Cell yield and viability were assessed by trypan blue the National Institutes of Health AIDS Research and Reagent Prostaining and counting. Viability, as assessed by trypan blue, was gram) was used as a control. This strain had a TCID 50 of 2,511,886 83.7% { 8.7% SD in 16 determinations for cultures derived from or 10
6.4
/mL, as determined on the A3.01 cell line. uninfected donors and 81.4% { 11.5% SD in 40 determinations for cultures derived from HIV-1-infected donors. Table 1 . Characteristics of HIV-1 -positive subjects whose peripheral blood was used to study the effect of HIV-1 infection on the Peripheral blood was obtained from 6 uninfected control T cell -generation capacity of progenitor cells. subjects and 13 HIV-1 -infected patients ( 2, the number of immature cells of both the CD4 and CD8 subsets that developed in cultures derived from HIV-1 -inin figure 1, there were no statistical differences in the numbers of CD4 / (P Å .94, ANOVA) or CD8 / (P Å .61, ANOVA) fected PBMC was 2-to 3-fold lower than the number that developed in cultures with control PBMC (P Å .03 and .05, cells that developed in culture for the 4 groups of HIV-1 -infected patients. These data show that PBMC from HIV-1 -respectively; Student's t test). The number of mature cells (for both subsets) in cultures derived from HIV-1 -infected PBMC infected patients are less capable of developing T cells of both the CD4 and the CD8 subsets in organ culture. The inability was more than 10-fold lower than the number for control cultures. At days 3, 6, and 9 of culture, development of immature to develop T cells occurred in all cases; even patients who had not experienced any peripheral CD4 depletion displayed a cells in cultures derived from HIV-1 -infected PBMC showed the same 2-to 3-fold decrease compared with that for controls; lower capacity to develop T cells in this system.
Results
The degree of T cell development was further examined by few mature cells were seen at these time points (data not shown). Since the development of both immature and mature the level of CD3 cell expression. The number of mature (those with high to moderate levels of CD3) and immature (those cells, as well as CD4 / CD8 / cells, was diminished, the developmental capability of HIV-1 -infected PBMC was affected very early in the T cell differentiation pathway.
Since T cell development was diminished in cultures derived from HIV-1 -infected PBMC, limit dilution analysis was done to determine if there was a change in the number of functional progenitor cells. / and CD8 / cells. These data suggest a frequency of progenitor T cells to be of the order of 1 in 10 5 total cells. This value is similar to what we have found previously [9] and suggests that the T cells produced in this system arise from immature progenitors rather than from contaminating mature T cells. Among the HIV-1 -infected patients, there was a failure to develop substantial numbers of cells of either subset at any inoculum (P Å .001 for CD4
/ cells, P Å .02 for CD8 / cells; ANOVA for HIV status and inoculum). These data show that there were fewer functional precursors in the peripheral blood of HIV-1 -infected donors.
Since previous studies had shown that the number of productively infected cells in the peripheral blood of asymptomatic patients was about 1 in 10 5 [14] , it was possible that a few infected cells had been transferred to the culture from the original inoculum. Therefore, we checked the culture fluid of 12-day cultures for HIV-1 replication, using the RT assay. A very low level of virus was found in cultures derived from HIV-1 -positive donors. Supernatant of cultures derived from PBMC of 8 HIV-1 -positive donors, 116 -1072 CD4 / cells/mL, gave a range of RT activity of 2275 -39,465 cpm/mL. The RT activity of the HIV-1 NL4-3 control (TCID 50 Å 125,594/mL) was 1,602,097 cpm/mL. There was no correlation between the CD4 . When 1 mg/mL zidovudine was added T cells remains to be determined and may differ between adults to cultures derived from uninfected subjects, there was no difand children infected with HIV-1. ference in the number of CD4 / or CD8 / cells that developed, Of interest, the number of CD8 / cells that developed in indicating that zidovudine at this dose had no effect on T cell organ cultures was also diminished even though CD8 / cell development. There was also no difference in either CD4 / (2.8 depletion does not occur in patients until very late stages of { 1. / cells/mL) in which zidovudine would presumably have blocked infection of newly developing cells. One of the cultures that was tested for RT activity with and without the in vitro addition of zidovudine was from a patient who had been on the drug for 2 years. RT activity was 2450 cpm/mL in cultures derived from this patient without the in vitro addition of zidovudine; the addition of zidovudine resulted in an RT activity of 1225 cpm/mL. There was no difference in the level of T cell development for patients treated with zidovudine and those not receiving antiviral therapy when zidovudine was added to the organ cultures. These data suggest that the infection of newly developing cells in culture was not responsible for the observed lack of T cell development with HIV-1 -infected PBMC.
Discussion
The present study shows that progenitors in peripheral blood of HIV-1 -infected patients display a diminished capacity to / cells/mL (ᮀ) were added to organ cultures (at 10 disease [16] . This dichotomy can be explained by the fact that [18] . TGF-b is a potent negative regulator of hematopoiesis, which acts by inhibiting entry into the cell cycle [19] and by while CD4
/ cells are a target for HIV-1 and are being lost in the periphery, CD8
/ cells are not. In addition, the CD8 / cells inducing apoptosis [20] . The TGF-b production activity of a few affected CD34 This mechanism may also explain the greater decrease in the production of mature T cells compared with that for immature We found that organ cultures derived from HIV-1 -infected donors produced very low levels of replicating virus. If the cells in cultures derived from HIV-1 -infected donors (table 2) . The production of TGF-b by even a small number of infected T infection of newly developing cells was completely responsible for the observed differences in T cell production among culcells during the culture period could also further decrease the development of mature T cells. At present, we cannot determine tures derived from HIV-1 -infected and uninfected PBMC, then a substantial increase in the number of CD4 / T cells would the mechanism by which T cell generation capacity is diminished in these patients. be expected when cultures were treated with zidovudine. In fact, cultures derived from HIV-1 -infected PBMC that were
The data presented here show that the ability of HIV-1 -infected persons to develop T cells is severely impaired. The treated with zidovudine produced the same low numbers of T cells as untreated cultures. Since zidovudine is known to interdata also demonstrate that the reduction in T cell development capacity occurs in an early T cell progenitor cell population, fere with new exogenous HIV-1 infection in organ culture [8] , these data suggest that the infection of newly developing T suggesting that our results may also apply to the generation of T cells in pediatric patients infected with HIV. The inability cells in culture was not responsible for the observed lack of T cell development with HIV-1 -infected PBMC. However, we to develop substantial numbers of T cells occurs very early in infection; even patients who are considered immunologically cannot rule out that virus or viral products made by a small number of T cells that had been infected prior to organ culture, normal displayed this defect, and patients treated after initiation of infection showed no improvement in their ability to produce and therefore unaffected by zidovudine treatment in the cultures, could have affected T cell development. To determine T cell progenitors. Our data on T cell lineage development, combined with the data on other hematopoeitic lineages, sugthe contribution of virus or viral products in organ culture to the decrease in T cell development observed with HIV-1 -gest that future therapeutic regimens for HIV-1 infection must include therapies designed to be used before T cell progenitors infected PBMC, the production of virus and viral products would have to be completely abrogated.
are affected. The results of limit dilution experiments in the organ culture system suggest that there is a reduction in the frequency of blood and home to some other site in the body. Second, the production of T cell precursors can be decreased in the bone marrow by alteration of bone marrow stromal cells or the hema-the bone marrow of some infected patients [6] . One mechanism 
